We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Curtiss-Wright
CW
$26.9B
| $1.85M | ﹤0.01% |
29,614
-1,231
| -4% | -$82.8K |
|
1377
Celldex Therapeutics
CLDX
$2.79B
| $1.85M | ﹤0.01% |
11,687
-10,889
| -48% | -$3.08M |
|
1378
CALL
Invesco QQQ Trust
QQQ
$445B
| $1.82M | ﹤0.01% |
+17,900
| New | +$1.92M |
|
|
FMER
1379
DELISTED
FIRSTMERIT CORP
FMER
| $1.82M | ﹤0.01% |
103,037
-5,066
| -5% | -$95.1K |
|
|
NTUS
1380
DELISTED
Natus Medical Inc
NTUS
| $1.82M | ﹤0.01% |
46,054
-547
| -1% | -$23.2K |
|
1381
Allegiant Air
ALGT
$2.73B
| $1.81M | ﹤0.01% |
8,373
-379
| -4% | -$79.5K |
|
|
SF
1382
Stifel
SF
$12.8B
| $1.8M | ﹤0.01% |
96,448
-2,930
| -3% | -$66.3K |
|
1383
Cal-Maine
CALM
$4.42B
| $1.8M | ﹤0.01% |
32,909
+6,364
| +24% | +$341K |
|
1384
Travere Therapeutics
TVTX
$5.2B
| $1.79M | ﹤0.01% |
88,552
-2,244
| -2% | -$66.5K |
|
|
WGL
1385
DELISTED
Wgl Holdings
WGL
| $1.79M | ﹤0.01% |
31,064
-1,323
| -4% | -$72.8K |
|
|
NGHC
1386
DELISTED
National General Holdings Corp
NGHC
| $1.79M | ﹤0.01% |
92,714
+67,390
| +266% | +$1.38M |
|
|
UIL
1387
DELISTED
UIL HOLDINGS
UIL
| $1.78M | ﹤0.01% |
35,515
-1,400
| -4% | -$66.2K |
|
1388
Royal Gold
RGLD
$16.6B
| $1.75M | ﹤0.01% |
37,241
+116
| +0.3% | +$5.97K |
|
1389
Deluxe
DLX
$1.25B
| $1.74M | ﹤0.01% |
31,259
-1,097
| -3% | -$66.1K |
|
1390
Viasat
VSAT
$10.1B
| $1.74M | ﹤0.01% |
27,006
-995
| -4% | -$60.7K |
|
1391
Southwest Gas
SWX
$6.7B
| $1.73M | ﹤0.01% |
29,683
-1,524
| -5% | -$84.2K |
|
1392
Polaris
PII
$4.07B
| $1.72M | ﹤0.01% |
14,361
+5,249
| +58% | +$712K |
|
1393
Prothena Corp
PRTA
$448M
| $1.72M | ﹤0.01% |
37,860
-466
| -1% | -$27.1K |
|
|
WEB
1394
DELISTED
Web.com Group, Inc.
WEB
| $1.72M | ﹤0.01% |
81,430
+51,543
| +172% | +$1.18M |
|
1395
CALL
iShares Russell 2000 ETF
IWM
$80.4B
| $1.72M | ﹤0.01% |
+15,700
| New | +$1.86M |
|
1396
NETGEAR
NTGR
$663M
| $1.72M | ﹤0.01% |
58,805
+36,134
| +159% | +$1.1M |
|
|
LIOX
1397
DELISTED
Lionbridge Technologies
LIOX
| $1.71M | ﹤0.01% |
345,171
+71,302
| +26% | +$398K |
|
|
CNW
1398
DELISTED
CON-WAY INC.
CNW
| $1.69M | ﹤0.01% |
35,557
-1,805
| -5% | -$70.7K |
|
1399
Targa Resources
TRGP
$56.2B
| $1.68M | ﹤0.01% |
32,670
+25,447
| +352% | +$1.86M |
|
|
HCC
1400
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $1.68M | ﹤0.01% |
21,636
+7,276
| +51% | +$563K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.